| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 92,309 | 50,632 | 69,323 | 44,194 | | Cost of Revenue | 12,681 | 14,974 | 14,000 | 15,405 | | | Gross Profit |
-
| 35,658 | 55,323 | 28,789 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 19,871 | 20,008 | 15,214 | 13,382 | | Non Recurring | 2,187 |
-
|
-
| 7,386 | | Others | 12,691 | 6,624 | 8,985 | (286) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 9,026 | 31,124 | 8,307 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 44,879 | 9,026 | 31,124 | 8,307 | | Interest Expense | 3,256 | 3,467 | 2,746 | 3,139 | | Income Before Tax | 41,623 | 5,559 | 28,378 | 5,168 | | Income Tax Expense | 14,058 | 1,423 | 10,119 | 1,599 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 27,565 | 4,136 | 18,259 | 3,569 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 27,565 | 4,136 | 18,259 | 3,569 | | Preferred Stock And Other Adjustments | (850) | (842) | (824) | (242) | | | Net Income Applicable To Common Shares | $26,715 | $3,294 | $17,435 | $3,327 |
|
0.31% Nasdaq 
0.05%
Income Statement
